| Titre : | Gabapentinoids: repeating mistakes of the past? [Editorial] (2022) |
| Auteurs : | B. MURNION ; A. SCHAFFER ; R. CAIRNS ; J. BRETT |
| Type de document : | Article : Périodique |
| Dans : | Addiction (Vol.117, n°12, December 2022) |
| Article en page(s) : | 2969-2971 |
| Langues: | Anglais |
| Discipline : | SAN (Santé publique / Public health) |
| Mots-clés : |
Thésaurus mots-clés PREGABALINE ; ANTICONVULSIVANTS ; MEDICAMENTS ; PHENOMENE EMERGENT ; MESUSAGE ; ANTALGIQUES ; FACTEUR DE RISQUE ; REGLEMENTATION |
| Mots-clés: | gabapentinoïdes |
| Résumé : | Gabapentinoid abuse and harms are increasing proportional to increased prescribing. Despite early indicators of problems and similar patterns with other drugs, regulatory controls over promotion and availability were introduced only after significant harms. Prescribers and consumers need new regulatory approaches to support quality use of high-risk medicines. |
| Domaine : | Autres substances / Other substances |
| Sous-type de document : | Editorial |
| Refs biblio. : | 19 |
| Affiliation : | Clinical Pharmacology and Toxicology, St Vincent's Hospital, Darlinghurst, NSW, Australia |
| Cote : | Abonnement |
| URL : | Société Française de Pharmacologie et de Thérapeutique (11/12/2022) |
| Lien : | https://doi.org/10.1111/add.15970 |
Accueil
